Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

NCT00838955 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped There was lack of enrollment since January 2013

Conditions

Hodgkin's Lymphoma

Interventions

DRUG: Temsirolimus

Sponsor

Loyola University

Collaborators

[object Object]